The dawn of neuroprotective therapy for glaucomatous optic neuropathy

Journal of Japanese Ophthalmological Society

Volumn 105, Issue 12, 2001, Pages 867-883

  Yamamoto, Tetsuya ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Glaucoma; Glaucomatous optic neuropathy; Neuroprotection; Normal tension glaucoma

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; IGANIDIPINE; NEUROPROTECTIVE AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL; APOPTOSIS; CYTOLOGY; ELECTRORETINOGRAPHY; GLAUCOMA; HUMAN; OPTIC NERVE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; RETINA GANGLION CELL; REVIEW; WISTAR RAT;

ANIMALS; APOPTOSIS; CALCIUM CHANNEL BLOCKERS; ELECTRORETINOGRAPHY; GLAUCOMA; HUMANS; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RETINAL GANGLION CELLS;

EID: 0035756234     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Quigley HA, Green WR : The histology of human glaucoma cupping and optic nerve damage. Clinicopathologic correlation in 21 eyes. Ophthalmology 86 : 1803-1830, 1979.